Clinical Trial Update: Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating a combination chemotherapy regimen in patients with germ cell tumors that have not responded to cisplatin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Testicular Germ Cell Tumor

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Ovarian Cancer, Testicular Germ Cell Tumor | Phase 1, Phase 2 | Status: COMPLETED